PC2 is especially designed for prostate cancer patients. PC2 helps decrease PSA count and promotes apoptosis, has antiangiogenic, cytostatic and cytotoxic effects. PC2 contains Ganoderma lucidum, has an ability to modulate the androgen receptor activation of transcription from prostate-specific antigen promoter in PCa cells.
Actions:
Promotes apoptosis
Anti-angiogenic
Helps decrease PSA count
Cytostatic
Cytotoxic
Indications:
Prostate Cancer
Combinations:
Cancer protocols